Circulating tumor DNA dynamics and response to immunotherapy in colorectal cancer

Circulating tumor DNA (ctDNA) is increasingly being investigated as a tool to detect minimal residual disease in resected, stage I-III colorectal cancer. Recent ctDNA studies have indicated that detection of ctDNA following surgery for resectable colorectal cancer confers a significantly higher risk...

Descripción completa

Detalles Bibliográficos
Autores principales: Gong, Jun, Aguirre, Francesca, Hazelett, Dennis, Alvarez, Rocio, Zhou, Lisa, Hendifar, Andrew, Osipov, Arsen, Zaghiyan, Karen, Cho, May, Gangi, Alexandra, Hitchins, Megan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9022091/
https://www.ncbi.nlm.nih.gov/pubmed/35463213
http://dx.doi.org/10.3892/mco.2022.2533

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9022091/
https://www.ncbi.nlm.nih.gov/pubmed/35463213
http://dx.doi.org/10.3892/mco.2022.2533

Ejemplares similares